T39. NEURAL MECHANISMS OF METABOTROPIC GLUTAMATE RECEPTOR 3 MEDIATED ENHANCEMENT OF SYNAPTIC PLASTICITY AND COGNITION

BACKGROUND: The group II metabotropic glutamate receptor 3 (mGlu3) is an emerging therapeutic target for schizophrenia, as research has demonstrated a link between mutations in the human gene encoding for mGlu3, GRM3, and clinical diagnosis of schizophrenia. Schizophrenia is known to be accompanied...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Schizophr Bull
Hlavní autoři: Stansley, Branden, Joffe, Max, Yohn, Samantha, Lindsley, Craig, Niswender, Colleen, Jeffrey Conn, P
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888595/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby016.315
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky